Consolidated Statements of Income (Loss) - USD ($) shares in Thousands, $ in Thousands	12 Months Ended
	Dec. 31, 2015	Dec. 31, 2014	Dec. 31, 2013
Revenues:
Product sales and services	$ 172,488	$ 11,993	$ 1,153
License and research revenue	721	2,782	3,026
Total	173,209	14,775	4,179
Operating expenses:
Cost of products and services sold	10,921	3,383	562
Research and development expenses	25,608	17,298	15,966
Selling, general and administrative expenses	21,712	15,698	13,216
Intangible asset amortization	12,564	11,749	0
Changes in fair value of related party acquisition-related contingent consideration	30,957	57,491	28,135
Loss on early repayment of related party acquisition-related note	0	3,013	0
Total	101,762	108,632	57,879
Operating income (loss)	71,447	(93,857)	(53,700)
Investment Income	2,651	963	254
Interest Expense	(1,415)	(5,747)	(2,602)
Interest Expense - changes in fair value of financing-related contingent consideration	(4,883)	(3,525)	(1,990)
Foreign exchange gain (loss)	10,594	11,871	(288)
Other income (expense)	0	(36)	573
Income (loss) before income taxes	78,394	(90,331)	(57,753)
Income tax provision (benefit)	37,735	(1,407)	(11,244)
Net income (loss) from continuing operations	40,659	(88,924)	(46,509)
Net income from discontinued operations	0	4,018	3,584
Net income (loss)	$ 40,659	$ (84,906)	$ (42,925)
Earnings (loss) per share - Basic:
Continuing operations	$ 1.00	$ (2.45)	$ (1.83)
Discontinued operations	0	0.11	0.14
Net income (loss)	1.00	(2.34)	(1.69)
Earnings (loss) per share - Diluted:
Continuing operations	0.93	(2.45)	(1.83)
Discontinued operations	0	0.11	0.14
Net income (loss)	$ 0.93	$ (2.34)	$ (1.69)
Earnings (loss) per share
Weighted average number of shares outstanding - Basic (in shares)	40,580	36,214	25,450
Weighted average number of shares outstanding - Diluted (in shares)	43,619	36,214	25,450